Adverse Events
Nada Alsuhebany, BSPharmD, PharmD, BCOP; Marti Larriva, PharmD, BCPS, BCOP; Ali McBride, PharmD, MS, BCPS, BCOP, FASHP; Krisstina Gowin, DO
Donyika Joseph, PharmD, BCOP; Farnaz Foolad, PharmD, BCPS; Neelam K. Patel, PharmD, BCOP;
Meghan Karuturi, MD, MSc; Jaime Kaushik, PharmD, BCOP
Jessie Signorelli, PharmD, BCOP; Amir T. Fathi, MD; Gabriela Hobbs, MD
Spontaneous Tumor Lysis Syndrome in a Patient with Stage IV HER2-Positive Breast Cancer: Case Report
Blake T. Robbins, PharmD, MBA; Alexander M. Kreimer, PharmD, BCPS; Reema A. Patel, MD;
Allison R. Butts, PharmD, BCOP
Kevin Straughn, PharmD; Robin Hardie-Hood, MD; Jordan Carrera, PharmD, BCPS, BCOP
Parikshit Padhi, MD, MBBS; Traci M. White, PharmD, PhC, BCGP; Neslihan Cetin, MD
Jiyeon Joy Park, PharmD, BCOP; Esther Huang, PharmD, BCPS, BCOP; Colleen Ciccosanti, DO, MPH
Vincent J. Cascone, PharmD, BCOP
Katherine P. Morgan, PharmD, BCOP, CPP; Yujiao Sun, PharmD; Allison Deal; Jared Weiss, MD;
Amber Cipriani, PharmD, BCOP
Jessica M. Tran, PharmD, BCPS; Ni-Chi Wu, PharmD, BCOP, BCPS; Rajkumar J. Sevak, PhD, RPh;
Pankaj Gupta, MD, FACP